Scaled it.
Taken it public.
Twice.
Now I do it for you.

Kleine & Co. · Strategic Consulting

The firm built by someone who has actually done it.

We partner with private equity, venture capital, and private companies navigating the moments that define an enterprise — growth, transformation, and exit. With deep expertise in life sciences, pharma, and healthcare.

Request a conversation Our track record

About

Joe Kleine

Founder & Principal

Built on decades at the highest levels of healthcare and life sciences.

Joe Kleine has spent three decades at the intersection of strategy, commercial execution, and value creation in life sciences and healthcare.

He has taken two companies public, led what was at the time the largest brand in the pharmaceutical industry, and engineered a turnaround that produced the fastest-growing company in its sector. His teams have negotiated over a billion dollars in commercial services — from both sides of the table — and he has hired, trained, and scaled multiple high-performance commercial organizations from the ground up.

Joe has also invested in and advised a startup that was acquired by a leading global provider of analytics and clinical research services to the life sciences industry.

What sets Joe apart is simple: he has never just advised. He has always operated.

That experience is what he now brings to a select group of private equity firms, venture capital investors, and private companies navigating the moments that define an enterprise.

Discreet by nature and selective by design.

San Francisco, CA · Nashville, TN

Track Record

A career defined by creating new markets and maximizing investor returns.

Two Successful IPOs

Took two companies the full journey to public markets — from growth strategy to the opening bell.

Turnaround & Market Leadership

Full turnaround of an unprofitable company into the fastest-growing in its industry.

Led the Industry’s Largest Brand

Led what was at the time the largest brand in the pharmaceutical industry.

$1B+ Closed

Over a billion dollars in pharma and healthcare services negotiated — from both sides of the table.

Acquisition Exit

Advised a startup acquired by a leading global provider of analytics and clinical research services to life sciences.

Services

We engage where the stakes are highest.

IPO Readiness & Execution

Hands-on guidance through the full journey to public markets — from growth strategy and investor positioning to the opening bell.

Turnaround & Value Creation

Diagnosis, restructuring, and execution for companies that need to move from underperformance to category leadership.

Commercial Organization Building

Hiring, training, and scaling high-performance commercial teams — built from scratch or upleveled for the next stage of growth.

Commercial Negotiation & Strategy

Over a billion dollars in services negotiated across pharma and healthcare — from both sides of the table, with the instincts that only come from building the teams that do the selling.

Investor & Board Advisory

Ongoing strategic counsel for PE and VC sponsors — portfolio reviews, management assessments, and value creation planning.

Startup Advisory

For founders with serious ambitions: positioning, fundraising strategy, and a direct line to hard-won C-level operating experience.

Leadership Elevation

Assessing, upgrading, and aligning leadership to match the ambition of the business — because strategy only moves as fast as the team executing it.

High-Stakes Negotiation

Bringing decades of experience negotiating from both sides of the table — with the instincts, relationships, and leverage that only come from having built and led the organizations doing the deal.

Commercial Assessment

For newly acquired portfolio companies, we offer a focused commercial assessment — scoped, time-bound, and built to move fast. A defined entry point that delivers clear outcomes and creates the foundation for what comes next.

Who We Work With

For alpha returns.

Our clients are private equity firms, venture capital investors, and private companies operating in pharma, life sciences, and healthcare-adjacent markets. They come to us when the decision is too important to get wrong. Engagements are accepted by introduction or referral.

Private Equity

Venture Capital

Private Companies

Life Sciences & Healthcare